Cost analysis of anticancer chemotherapy and chemoirradiation regimens considering the drugs marketed through Jan Aushadhi (People's Medicine) stores and their branded counterparts: First cost comparison study.

Autor: Krishna, Abhishek¹ (AUTHOR), Simon, Paul¹ (AUTHOR), Palatty, Princy L.² (AUTHOR), Sacheendran, Dhanya² (AUTHOR), Jayachandran, Mamatha² (AUTHOR), George, Thomas³ (AUTHOR), Baliga, M. S.⁴ (AUTHOR) msbaliga.mio@gmail.com

Publikováno v: Journal of Cancer Research & Therapeutics. Jul-Sep2024, Vol. 20 Issue 5, p1472-1485. 14p.

Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma—Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation.

Autor: Krauze, Andra V.¹ (AUTHOR) andra.krauze@nih.gov, Zhao, Yingdong² (AUTHOR) zhaoy@mail.nih.gov, Li, Ming-Chung² (AUTHOR) limingc@mail.nih.gov, Shih, Joanna² (AUTHOR) jshih@mail.nih.gov, Jiang, Will¹ (AUTHOR) uma@mail.nih.gov, Tasci, Erdal¹ (AUTHOR) philip.tofilon@nih.gov, Cooley Zgela, Theresa¹ (AUTHOR), Sproull, Mary¹ (AUTHOR), Mackey, Megan¹ (AUTHOR), Shankavaram, Uma¹ (AUTHOR), Tofilon, Philip¹ (AUTHOR), Camphausen, Kevin¹ (AUTHOR)

Publikováno v: Biomolecules (2218-273X). Oct2023, Vol. 13 Issue 10, p1499. 20p.

Pharmacoeconomic Appraisal of Treating Head and Neck Cancer with Various Chemotherapy and Chemoirradiation Regimens Using Branded and Jan-aushadhi Drugs in India.

Autor: Krishna, Abhishek¹ (AUTHOR), Jayachandran, Mamatha² (AUTHOR), Sacheendran, Dhanya² (AUTHOR), George, Thomas³ (AUTHOR), Palatty, Princy Louis^2,4 (AUTHOR) drprincylouispalatty@gmail.com, Baliga, Manjeshwar Shrinath^4,5,6 (AUTHOR) msbaliga@gmail.com

Publikováno v: Indian Journal of Otolaryngology & Head & Neck Surgery. Sep2023, Vol. 75 Issue 3, p1782-1791. 10p.

Correction: Tasci et al. RadWise: A Rank-Based Hybrid Feature Weighting and Selection Method for Proteomic Categorization of Chemoirradiation in Patients with Glioblastoma. Cancers 2023, 15 , 2672.

Autor: Tasci E; Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Bethesda, MD 20892, USA., Jagasia S; Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Bethesda, MD 20892, USA., Zhuge Y; Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Bethesda, MD 20892, USA., Sproull M; Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Bethesda, MD 20892, USA., Cooley Zgela T; Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Bethesda, MD 20892, USA., Mackey M; Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Bethesda, MD 20892, USA., Camphausen K; Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Bethesda, MD 20892, USA., Krauze AV; Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Bethesda, MD 20892, USA.

Publikováno v: Cancers [Cancers (Basel)] 2024 Aug 01; Vol. 16 (15). Date of Electronic Publication: 2024 Aug 01.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.